Cargando…

Cost trends among commercially insured and Medicare Advantage-insured patients with chronic obstructive pulmonary disease: 2006 through 2009

BACKGROUND: Few estimates of health care costs related to chronic obstructive pulmonary disease (COPD) are available regarding commercially insured patients in the United States. The aims of this retrospective observational analysis of administrative data were to describe and compare health care res...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dalal, Anand A, Liu, Fang, Riedel, Aylin A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2011
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3206770/ https://www.ncbi.nlm.nih.gov/pubmed/22069365 http://dx.doi.org/10.2147/COPD.S24591

Ejemplares similares

Trends in Testosterone Prescriptions for Older Men Enrolled in Commercial Insurance and Medicare Advantage
por: Everhart, Alexander, et al.
Publicado: (2021)

Use of Telemedicine for Buprenorphine Inductions in Patients With Commercial Insurance or Medicare Advantage
por: Barsky, Benjamin A., et al.
Publicado: (2022)

Trends in opioid use in commercially insured and Medicare Advantage populations in 2007-16: retrospective cohort study
por: Jeffery, Molly Moore, et al.
Publicado: (2018)

Association of Health Insurance Literacy With Enrollment in Traditional Medicare, Medicare Advantage, and Plan Characteristics Within Medicare Advantage
por: Park, Sungchul, et al.
Publicado: (2022)

Comparison of Diabetes Medications Used by Adults With Commercial Insurance vs Medicare Advantage, 2016 to 2019
por: McCoy, Rozalina G., et al.
Publicado: (2021)

Insurance Trends for the Medicare Population, 1991-1999
por: Murray, Lauren A., et al.
Publicado: (2002)

Increasing Trends in the Use of Hospital Observation Services for Older Medicare Advantage and Privately Insured Patients
por: Lind, Keith D., et al.
Publicado: (2017)

Prescription Drug Coverage for Treatment of Low Back Pain Among US Medicaid, Medicare Advantage, and Commercial Insurers
por: Lin, Dora H., et al.
Publicado: (2018)

Trends in Medicare Supplementary Insurance: 1992-96
por: Eppig, Franklin J., et al.
Publicado: (1997)

Out-of-Pocket Costs for Colposcopy Among Commercially Insured Women From 2006 to 2019
por: Fendrick, A. Mark, et al.
Publicado: (2022)

Trends in Disenrollment and Reenrollment Within US Commercial Health Insurance Plans, 2006-2018
por: Fang, Hanming, et al.
Publicado: (2022)

Patterns of Comorbidity and Multimorbidity Among Patients With Multiple Sclerosis in a Large US Commercially Insured and Medicare Advantage Population
por: Dai, Dingwei, et al.
Publicado: (2022)

Direct costs of chronic obstructive pulmonary disease among managed care patients
por: Dalal, Anand A, et al.
Publicado: (2010)

Trends in Gabapentin Prescribing in a Commercially Insured U.S. Adult Population, 2009-2016
por: Pauly, Nathan J., et al.
Publicado: (2020)

Comparison of Ambulatory Care Access and Quality for Beneficiaries With Disabilities Covered by Medicare Advantage vs Traditional Medicare Insurance
por: Johnston, Kenton J., et al.
Publicado: (2022)

Compared to commercially insured patients, Medicare advantage patients adopt newer diabetes drugs more slowly and adhere to them less
por: Flory, James H, et al.
Publicado: (2021)

Evaluation of Potentially Avoidable Acute Care Utilization Among Patients Insured by Medicare Advantage vs Traditional Medicare
por: Beckman, Adam L., et al.
Publicado: (2023)

Out-of-Pocket Costs and Prescription Filling Behavior of Commercially Insured Individuals With Chronic Obstructive Pulmonary Disease
por: Patel, Bhavin, et al.
Publicado: (2022)

FRI528 Trends And Components Of Thyroid Status Evaluation In Commercially Insured Adults In The US, 2006-2020
por: Morris, Earl J, et al.
Publicado: (2023)

Can Insurance Market Competition Coexist With Provider Price Regulation? Evidence From Medicare Advantage
por: Berenson, Robert A., et al.
Publicado: (2019)

588. Retrospective Analysis of Clinical Characteristics and Treatment Patterns Among HIV Patients with Commercial and Medicare Advantage Health Insurance in the United States
por: Priest, Julie, et al.
Publicado: (2018)

Comorbidity Associations with AATD Among Commercially Insured and Medicare Beneficiaries with COPD in the US
por: Sandhaus, Robert, et al.
Publicado: (2020)

The cost burden of oral, oral pharyngeal, and salivary gland cancers in three groups: commercial insurance, medicare, and medicaid
por: Jacobson, Jed J, et al.
Publicado: (2012)

Medical Claim Cost Impact of Improved Diabetes Control for Medicare and Commercially Insured Patients with Type 2 Diabetes
por: Fitch, Kathryn, et al.
Publicado: (2013)

Incidence and prevalence of idiopathic inflammatory myopathies among commercially insured, Medicare supplemental insured, and Medicaid enrolled populations: an administrative claims analysis
por: Smoyer-Tomic, Karen E, et al.
Publicado: (2012)

Out-of-Pocket Costs for Colonoscopy After Noninvasive Colorectal Cancer Screening Among US Adults With Commercial and Medicare Insurance
por: Fendrick, A. Mark, et al.
Publicado: (2021)

More surgery in December among US patients with commercial insurance is offset by unrelated but lesser surgery among patients with Medicare insurance
por: Dexter, Franklin, et al.
Publicado: (2022)

Patient Perspectives on the Burden of Heart Failure with Preserved Ejection Fraction in a US Commercially Insured and Medicare Advantage Population: A Survey Study
por: Nguyen, Chi, et al.
Publicado: (2023)

Real-World Treatment Patterns and Switching Following Moderate/Severe Chronic Obstructive Pulmonary Disease Exacerbation in Patients with Commercial or Medicare Insurance in the United States
por: Bogart, Michael, et al.
Publicado: (2023)

Costs of pediatric liver transplantation among commercially insured and Medicaid-insured patients with cholestasis in the US
por: Miloh, Tamir, et al.
Publicado: (2023)

Socioeconomic factors and Medicare supplemental health insurance
por: Garfinkel, Steven A., et al.
Publicado: (1987)

Is a Refundable Deductible Insurance an advantage for the insured? a mathematical approach
por: Claramunt, M. Mercè, et al.
Publicado: (2021)

915 Is a hospital's surgical site infection rate among Medicare-insured patients a good indicator of outcome for commercially-insured patients?
por: Calderwood, Michael S., et al.
Publicado: (2014)

Cost Sharing, Supplementary Insurance, and Health Services Utilization Among the Medicare Elderly
por: Link, Charles R., et al.
Publicado: (1980)

Multiple Comorbidities, Psychiatric Disorders, Healthcare Resource Utilization and Costs Among Adults with Essential Tremor: A Retrospective Observational Study in a Large US Commercially Insured and Medicare Advantage Population
por: Dai, Dingwei, et al.
Publicado: (2022)

Medicare Influence on Private Insurance: Good or Ill?
por: Jones, Stanley B.
Publicado: (1996)

Savings estimate for a Medicare insured group
por: Birnbaum, Howard, et al.
Publicado: (1991)

Alcohol-Attributable Medical Costs in Commercially Insured and Medicaid Populations
por: Ozluk, Pelin, et al.
Publicado: (2022)

Trends in Use of Robotic Surgery for Privately Insured Patients and Medicare Fee-for-Service Beneficiaries
por: Bonner, Sidra N., et al.
Publicado: (2023)

Healthcare Costs of Clostridioides difficile Infection in Commercially Insured Younger Adults
por: Sahrmann, John M, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_tbfoinqsk1b54l2tf07ad5im6q